Andrea Knight1, Pamela Weiss2, Knashawn Morales3, Marsha Gerdes4, Melissa Rearson5, Michelle Vickery6, Ron Keren7. 1. Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA; Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA; Children's Hospital of Philadelphia PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA. Electronic address: knighan@email.chop.edu. 2. Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA; Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA. 3. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA. 4. Children's Hospital of Philadelphia PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA; Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA. 5. Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA. 6. Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA; Children's Hospital of Philadelphia PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA. 7. Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA; Division of General Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
Abstract
OBJECTIVE: To investigate differences in risk factors for depression and anxiety, such as central nervous system involvement in systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD), by comparing youth with SLE/MCTD to peers with type 1 diabetes mellitus (T1D). STUDY DESIGN: We conducted a cross-sectional study of 50 outpatient pairs, ages 8 years and above, matching subjects with SLE/MCTD and T1D by sex and age group. We screened for depression, suicidal ideation, and anxiety using the Patient Health Questionnaire-9 and the Screen for Childhood Anxiety Related Emotional Disorders, respectively. We collected parent-reported mental health treatment data. We compared prevalence and treatment rates between subjects with SLE/MCTD and T1D, and identified disease-specific risk factors using logistic regression. RESULTS: Depression symptoms were present in 23%, suicidal ideation in 15%, and anxiety in 27% of participants. Compared with subjects with T1D, subjects with SLE/MCTD had lower adjusted rates of depression and suicidal ideation, yet poorer rates of mental health treatment (24% vs 53%). Non-White race/ethnicity and longer disease duration were independent risk factors for depression and suicidal ideation. Depression was associated with poor disease control in both groups, and anxiety with insulin pump use in subjects with T1D. CONCLUSION: Depression and anxiety are high and undertreated in youth with SLE/MCTD and T1D. Focusing on risk factors such as race/ethnicity and disease duration may improve their mental health care. Further study of central nervous system and other disease-related factors may identify targets for intervention.
OBJECTIVE: To investigate differences in risk factors for depression and anxiety, such as central nervous system involvement in systemic lupus erythematosus (SLE)/mixed connective tissue disease (MCTD), by comparing youth with SLE/MCTD to peers with type 1 diabetes mellitus (T1D). STUDY DESIGN: We conducted a cross-sectional study of 50 outpatient pairs, ages 8 years and above, matching subjects with SLE/MCTD and T1D by sex and age group. We screened for depression, suicidal ideation, and anxiety using the Patient Health Questionnaire-9 and the Screen for Childhood Anxiety Related Emotional Disorders, respectively. We collected parent-reported mental health treatment data. We compared prevalence and treatment rates between subjects with SLE/MCTD and T1D, and identified disease-specific risk factors using logistic regression. RESULTS:Depression symptoms were present in 23%, suicidal ideation in 15%, and anxiety in 27% of participants. Compared with subjects with T1D, subjects with SLE/MCTD had lower adjusted rates of depression and suicidal ideation, yet poorer rates of mental health treatment (24% vs 53%). Non-White race/ethnicity and longer disease duration were independent risk factors for depression and suicidal ideation. Depression was associated with poor disease control in both groups, and anxiety with insulin pump use in subjects with T1D. CONCLUSION:Depression and anxiety are high and undertreated in youth with SLE/MCTD and T1D. Focusing on risk factors such as race/ethnicity and disease duration may improve their mental health care. Further study of central nervous system and other disease-related factors may identify targets for intervention.
Authors: D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay Journal: J Rheumatol Date: 1992-11 Impact factor: 4.666
Authors: Janet Silverstein; Georgeanna Klingensmith; Kenneth Copeland; Leslie Plotnick; Francine Kaufman; Lori Laffel; Larry Deeb; Margaret Grey; Barbara Anderson; Lea Ann Holzmeister; Nathaniel Clark Journal: Diabetes Care Date: 2005-01 Impact factor: 19.112
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Fabiano G Nery; Eduardo F Borba; John P Hatch; Jair C Soares; Eloísa Bonfá; Francisco Lotufo Neto Journal: Compr Psychiatry Date: 2006-05-24 Impact factor: 3.735
Authors: Wilmer L Sibbitt; John R Brandt; Courtney R Johnson; Marcos E Maldonado; Samir R Patel; Corey C Ford; Arthur D Bankhurst; William M Brooks Journal: J Rheumatol Date: 2002-07 Impact factor: 4.666
Authors: Carrie M Bernstein; Melissa S Stockwell; Mary Pat Gallagher; Susan L Rosenthal; Karen Soren Journal: Clin Pediatr (Phila) Date: 2012-09-17 Impact factor: 1.168
Authors: Andrea Knight; Amy J Kogon; Matthew B Matheson; Bradley A Warady; Susan L Furth; Stephen R Hooper Journal: J Pediatr Date: 2017-07-19 Impact factor: 4.406
Authors: Kathrin Zimmerman; Bobby May; Katherine Barnes; Anastasia Arynchyna; Elizabeth N Alford; Caroline Arata Wessinger; Laura Dreer; Inmaculada Aban; James M Johnston; Curtis J Rozzelle; Jeffrey P Blount; Brandon G Rocque Journal: J Neurosurg Pediatr Date: 2020-07-24 Impact factor: 2.375
Authors: Paula Dagnino; María José Ugarte; Felipe Morales; Sofia González; Daniela Saralegui; Johannes C Ehrenthal Journal: Front Psychol Date: 2020-12-09
Authors: Kaveh Ardalan; Oluwatosin Adeyemi; Dawn M Wahezi; Anne E Caliendo; Megan L Curran; Jessica Neely; Susan Kim; Colleen K Correll; Emily J Brunner; Andrea M Knight Journal: Arthritis Care Res (Hoboken) Date: 2020-11-27 Impact factor: 4.794